Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by I.R. Matthews
Pin43 - A Cost-Effectiveness Analysis of Revaccinating Older Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23) Compared to Vaccinating With a Single Dose of Ppv23 in the United Kingdom (Uk)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or No Vaccination (NoVac) in the UK
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Phase III Clinical Trial to Evaluate the Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Healthy Children, Adults, and Elderly
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds With the 13-Valent Pneumococcal Conjugate Vaccine in England
PLoS ONE
Multidisciplinary
The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients With Rheumatoid Arthritis
Epidemiology and Vaccine Prevention
Efficacy and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients With Rheumatoid Arthritis
The Clinician
Immunogenicity and Tolerance of a 7-Valent Pneumococcal Conjugate Vaccine in Nonresponders to the 23-Valent Pneumococcal Vaccine
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Public and Private Payer Perspectives on the Net Cost of Implementation of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Compared With 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR. Morbidity and mortality weekly report
Health Information Management
Mutagenesis
Epidemiology
Health
Medicine
Toxicology
PIN54 Cost-Effectiveness of 2+1 Dosing of 13-Valent Pneumococcal Conjugate Vaccine Compared With 2+1 Dosing of 10-Valent Conjugate Vaccine in Preventing Pneumococcal Disease in Canada
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
